Helen of Troy (HELE)
(Delayed Data from NSDQ)
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$68.04 USD
+1.34 (2.01%)
Updated Oct 18, 2024 03:59 PM ET
After-Market: $68.06 +0.02 (0.03%) 7:58 PM ET
3-Hold of 5 3
A Value C Growth A Momentum A VGM
Zacks News
Can Helen of Troy (HELE) Keep the Earnings Surprise Streak Alive?
by Zacks Equity Research
Helen of Troy (HELE) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Here is Why Growth Investors Should Buy Helen of Troy (HELE) Now
by Zacks Equity Research
Helen of Troy (HELE) is well positioned to outperform the market, as it exhibits above-average growth in financials.
Sanderson Farms' (SAFM) Shareholder-Friendly Moves Look Solid
by Zacks Equity Research
Sanderson Farms (SAFM), which recently raised its quarterly dividend, is benefiting from its strategic growth efforts.
Colgate Up More Than 10% YTD on Demand: Will It Move Higher?
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, costs and currency-related headwinds persist.
Nu Skin is Poised on Customer Base Growth & Product Pipeline
by Zacks Equity Research
Strength in Nu Skin's (NUS) customer base driven by its effective strategies is yielding. Also, it is focused on empowering sales leaders through engaging technology platforms.
Coronavirus-Led Woes Hurt Coty (COTY), E-commerce Looks Solid
by Zacks Equity Research
Weakness in the Consumer Beauty segment along with currency headwinds are a concern for Coty (COTY). Nevertheless, its strategic partnerships and online business bode well.
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
by Zacks Equity Research
Zacks Industry Outlook Highlights: Helen of Troy, Nu Skin, Inter Parfums, e.l.f. Beauty and Estee Lauder
NUS or HELE: Which Is the Better Value Stock Right Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
4 Cosmetics Stocks to Buff Up Your Portfolio Amid Industry Challenges
by Zacks Equity Research
The Zacks Cosmetics industry is facing COVID-19 woes like disturbed travel retail, low traffic and soft makeup demand. Rising demand for personal care products however bodes well for HELE, NUS, IPAR and ELF, which are focused on adapting to the changing market trends.
4 Factors That Make Helen of Troy (HELE) a Promising Stock
by Zacks Equity Research
Helen of Troy (HELE) is gaining on digital efforts and strength in Leadership Brands. The company's Health & Home segment is benefiting from pandemic-led demand.
Here's Why Nu Skin Stock is Up More Than 20% in Three Months
by Zacks Equity Research
Nu Skin (NUS) is seeing robust growth in its customer base courtesy of its effective strategies. Also, management recently raised its 2020 outlook.
Coty (COTY) Down on Wider-Than-Expected Q4 Loss & Drab Sales
by Zacks Equity Research
Coty's (COTY) fourth-quarter fiscal 2020 results reflect adverse impacts of coronavirus-led retail and salon closures. The company expects to return to profits in the first quarter of fiscal 2021.
NUS vs. HELE: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
NUS vs. HELE: Which Stock Is the Better Value Option?
Altria Gains From Oral Products Amid Lower Cigarette Sales
by Zacks Equity Research
Despite dismal cigarette sales, pricing power and growth in oral tobacco are offering Altria (MO) some respite.
Estee Lauder's (EL) Q4 Loss Wider Than Estimates, Sales Down
by Zacks Equity Research
Estee Lauder's (EL) fourth-quarter fiscal 2020 sales decline due to coronavirus-induced retail store closures. The company launches a two-year plan called Post-COVID Business Acceleration Program.
Newell Up More Than 32% in 3 Months: What's Driving the Stock?
by Zacks Equity Research
Robust consumption patterns and Project FUEL plan are likely to aid Newell Brands (NWL) amid the ongoing coronavirus woes.
Philip Morris Extends Deal With KT&G, RRPs Expansion on Track
by Zacks Equity Research
Philip Morris (PM) will start commercialization of KT&G's smoke-free alternatives outside South Korea, beginning with Russia.
Helen of Troy Looks Poised on Online Strength & High Demand
by Zacks Equity Research
Helen of Troy's (HELE) is gaining from strength in Leadership Brands and the solid online business. Also, rising pandemic-led demand in the Health and Home unit is an upside.
Philip Morris Gains on RRPs & Pricing Amid Low Cigarette Sales
by Zacks Equity Research
Philip Morris' (PM) cigarette sales have been dismal due to lower demand and pandemic-led restrictions. Nevertheless, RRPs are depicting continued rise.
Service Corporation Rewards Shareholders, Boosts Buyback Plan
by Zacks Equity Research
Service Corporation (SCI) increases share repurchase program by $431 million. Also, the company declares quarterly dividend that is payable on Sep 30, 2020.
Cleaning Product Demand Aids P&G's Growth: Will it Persist?
by Zacks Equity Research
Procter & Gamble (PG) is one of the beneficiaries of the recent spike in demand for cleaning and disinfecting products amid the pandemic. However, currency headwinds continue to play spoilsport.
Colgate's Sales Gain on Strong Demand Amid Currency Woes
by Zacks Equity Research
Colgate (CL) remains well placed with strong product demand, robust pricing efforts and sturdy online show, which are boosting organic sales. However, cost and currency-related headwinds continue.
Inter Parfums (IPAR) Posts Narrower-Than-Expected Q2 Loss
by Zacks Equity Research
Inter Parfums' (IPAR) second-quarter 2020 results reflect lower sales thanks to coronavirus-induced retail outlet closures. Also, sales declined across all regions and brands.
Helen of Troy (HELE) Down 1.8% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Helen of Troy (HELE) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Nu Skin's (NUS) Q2 Earnings Beat Estimates, Sales Decline Y/Y
by Zacks Equity Research
Nu Skin's (NUS) second-quarter 2020 results reflect lower earnings and sales. Nevertheless, management raises 2020 view on better than expected year-to-date performance.